Cannabis could help heart failure patients
A team of researchers discovered that cannabis may have some benefits for heart failure sufferers, but their finding should not be taken as a recommendation to consume cannabis.
At a’American Heart Association, Dr. Oluwole Adegbala, resident physician at Englewood Hospital in New Jersey, presented the findings of a currently unpublished study on the links between cannabis use and heart failure.
Previous studies further suggest that the consumption of cannabis may be linked to heart problems. That's why the researchers were surprised to find that cannabis users were less likely to suffer from atrial fibrillation, a heart condition that can worsen the symptoms of heart failure. In France, this condition affects 1% of the population, but more than 10% over the age of 80.
Dr. Adegbala and his team analyzed the records of more than 6 million heart failure patients admitted to hospital between 2007 and 2014. Around 23,000 patients had reported using cannabis without being dependent, and 1,200 were considered dependent users. Patient data were adjusted for age, socioeconomic status and use of other drugs.
Non-dependent users were 18% less likely to develop atrial fibrillation than non-users, and 46% less likely to die in hospital. Dependent users were 31% less likely to develop atrial fibrillation, and 58% less likely to die in hospital.
However, the researchers were unable to determine the exact reason why cannabis reduces the risk of atrial fibrillation or mortality in heart failure patients.
Previous research on animals had shown that hypertension and atherosclerosis, both risk factors for atrial fibrillation, could be reduced by activating cannabinoid receptors. Dr. Adegbala also notes that cannabidiol can reduce inflammation, another risk factor for atrial fibrillation.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project


You must be logged in to post a comment Login